GU and Kidney Flashcards

1
Q

Benign Mimics of Prostate Cancer

A

Normal Anatomy

Cowpers glands

Seminal vesicles / ejaculatory ducts

Paraganglia

Atrophy

Partial atrophy

Post atrophic hyperplasia

Benign Proliferations

Adenosis (AAH)

Sclerosing adenosis

Hyperplasia and Metaplasia

Basal cell hyperplasia

Clear cell cribriform hyperplasia

Verumonatum gland hyperplasia

Neophrogenic metaplasia

Mucinous metaplasia

Inflammation / Reactive

Malakoplakia

Granulomatous prostatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Staging of Prostate Cancer

A

AJCC 8th ed. (adenocarcinomas and histologic variants; NEC & other types)

pT Staging

pT2 = organ confined

pT3a = extraprostatic extension or bladder neck invasion

pT3b = seminal vesicle invasion

pT4 = tumour fixed or invades adjacent structures other than seminal vesicles e.g. bladder, rectum, levator muscles, external sphincter and pelvic wall

pN Staging

Regional lymph nodes

pM Staging

pM1a Non regional lymph nodes

pM1b Bone

pM1c Other sites with or without bony disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Reporting Elements for Radical Prostatectomy

A

Specimen type, weight and size of prostate gland

Histologic subtype of carcinoma

Histologic grade (Gleason Grade & ISUP Grade Group)

Presence of intraduct carcinoma (+ whether has been included in grading)

Volume of prostate involved by cancer - % and as site, size and location of dominant nodule

Perineural and lymphovascular space invasion

Extraprostatic extension (+ location of EPE)

Bladder neck invasion

Seminal vesicle invasion

Margin status and if EPE is present at positive margin

Nodal status (if included)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Reporting Elements of Prostate Core Biopsy

A

Specimen site, number of cores, length of cores

If cancer is present / absent

Histologic subtype of cancer (acinar, ductal, mixed, neuroendocrine)

Gleason Grade and ISUP Grade Group

Number of cores involved and length of tissue involved (mm)

Presence of intraduct carcinoma

Perineural invasion

Extraprostatic extension

Comment / Other findings as needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Staging of Testicular Cancer

A

AJCC 8th ed. (Germ Cell Tumours & Sex Cord Stromal Tumours).

pT Staging

pT0: No evidence of primary tumour

pTis: Germ cell neoplasia in situ only

pT1: Limited to testis (incl rete testis invasion) without lymphovascular space invasion

pT1a & b: Substaging for pure seminoma based on size < or > 3cm

pT2: Tumour limited to testis (incl rete testis invasion) with lymphovascular space invasion, or tumour invading hilar soft tissue or epididymis or through visceral mesothelial layer of tunica albuginea with or without lymphovascular space invasion

pT3: Tumour directly invades spermatic cord, with or without lymphovascular space invasion

pT4: Tumour directly invades scrotum, with or without lymphovascular space invasion

pN Staging

Regional lymph node metastases, number involved and size of lymph node mass (2, 5cm cut offs)

pM Staging

pM1a: non-retroperitoneal nodal or pulmonary metastases

pM1b: non-pulmonary viasceral metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Reporting Elements Testicular Cancer

A

Reporting Elements in Testicular Cancer

Clinical: pre and post serum markers

Site / Laterality of tumour

Focality (uni versus multi focal tumour)

Size of tumour

Histologic subtype (s) of tumour - GCT (and %), sex-cord stromal tumour

Extent of Invasion - rete testis, hilar soft tissue, epididymis, tunica albuginea, spermatic cord, scrotum

Lymphovacscular space invasion

Margin Status

Other findings: GCNIS, Tumour regression, Atrophy, Sertoli cell nodules etc.

Retroperitoneal lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Gleason Grading of Prostate Cancer

A

Five tier grading system based on architecture (cytologic features not included).

Reported as sum of most prevalent pattern (primary) and second most prevalent pattern (secondary) to give a combined Gleason score.

Gleason patterns 1 & 2 are exceedingly, usually seen on TURP specimens

Gleason Pattern 3:

Clearly infiltrative glands

Glands vary in shape and size

All glands are distinct and separated by stroma

Microcystic, atrophic, branching and pseudohyperplasitc glands are all considered pattern 3.

Gleason Pattern 4:

Glands no longer seen as separate - fused, poorly defined, cribiform or glomeruloid

Ductal adenocarcinoma and intraduct carcinoma (without necrosis) considered pattern 4.

Gleason Pattern 5:

Cells in solid nests and sheets, rosettes, cords or single cells with virtually no glandular differentiation

Nest of tumour with central comedonecrosis also classed as pattern 5.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ISUP Grade Groups (Prostate Cancer)

A

Why? ISUP Grade Groups

  • ease of communication of cancer diagnosis to patient
  • with grade groups best prognostic group is “1” not “3 + 3 = 6” which is clearly confusing
  • easier to compare outcomes in cancer research if grouped

ISUP Grade Groups

GG1: Gleason score 6 (3 + 3)

GG2: Gleason score 7 (3 + 4)

GG3: Gleason score 7 (4 + 3)

GG4: Gleason score 8 (4 + 4, 3 + 5, 5 + 3)

GG5: Gleason scores 9 & 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

WHO / ISUP Grading of Renal Cell Carcinoma

A

Grade.Nucleoli (400x).Nucleoli (100x).

  1. Absent / inconspicuous. Absent.
  2. Conspicuous & eosinophilic. Visible but not prominent.
  3. Prominent. Conspicuous and eosinophilic.
  4. Prominent. Prominent.

Only clear cell renal cell carcinoma and papillary renal cell carcinoma are graded

Tumours are graded by the worst area, however focal

Collecting duct carcinoma is considered ISUP grade 3 - 4

Grade 4 = marked nuclear pleomorphism, multi nucleated tumour giant cells, sarcomatoid and rhabdoid features.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Staging Bladder Cancer

A

AJCC 8th ed. (urothelial carcinoma & variants, Adenocarcinoma, SCC, NEC, sarcomatoid carcinoma)

m= multiple, r = recurrent, y = post treatment

pT Staging

pT0 No evidence of primary tumour

pTa Non-invasive papillary carcinoma

pTis Urothelial carcinoma in situ

pT1 Tumour invades lamina propria

pT2a Tumour invades superficial muscularis propria

pT2b Tumour invades deep muscularis propria

pT3a Tumour invades perivesical tissue microscopically

pT3b Tumour invades perivesical tissue macroscopically

pT4a Extravesical tumour invades directly into prostate stroma, uterus or vagina

pT4b Extravesical tumour invades pelvic wall or abdominal wall

pN Staging

pN1 Single regional lymph node metastasis in true pelvis

pN2 Multiple regional lymph node metastases in true pelvis

pN3 Lymph node metastasis to common iliac nodes

pM Staging

pM1a Distant metastases limited to lymph nodes beyond the common iliacs

pM1b Non lymph node metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Tumours Arising in GCNIS

A

Seminoma

Embryonal carcinoma

Choriocarcinoma

Post-pubertal teratoma

Post-pubertal Yolk Sac Tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tumours Not Arising in GCNIS

A

Spermatocytic tumour

Pre pubertal teratoma

Post pubertal teratoma

Non- Germ cell tumours e.g

Sex-cord stromal tumours

Mesenchymal tumours (eg RMS)

Haematolymphoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Reporting Elements of Renal Cell Carcinoma

A

Procedure and laterality

Focality (uni vs. multi)

Site and size of tumour

Histologic subtype

Histologic grade (ISUP grade for ccRCC and papillary)

Tumour extent: perinephric fat, Gerotas fascia, adrenal, renal sinus fat, pelvicalyceal systema, renal vein, IVC, adjacent organs.

Sarcomatoid and rhaboid features

Lymphovascular space invasion (excl. major vessels)

Tumour cell necrosis and %

Lymph nodes (regional and non-regional)

Margin status

Metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Staging System for Renal Cell Carcinomas

A

Based on size of tumour and extent of invasion

SIZE CUT OFFS = 4, 7, 10cm

pT1 = limited to kidney: pT1a < 4cm, pT1b 4 - 7 cm

pT2 = limited to kidney: pT2a 7 - 10cm, pT2b >10cm

pT3a = sinus fat, pelvicalyceal, renal vein, perinephric fat

pT3b/c = IVC above or below diphragm

pT4 = beyond Gerotas fascia including direct adrenal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DDx of Paediatric Renal Tumours

A

Embryonal Neoplasms

Nephrogenic rests

Paediatric cystic nephroma (DICER1)

Nephroblastoma & cystic partially differeniated nephroblastoma

Mesenchymal Tumours

Ossifying renal tumour of infancy

Congenital mesoblastic nephroma (classic & cellular)

Rhabdoid tumour

Clear cell sarcoma of kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

WHO 2022 Tumours of Renal Tubular Origin

A

Clear cell tumours:

ccRCC, multilocular cystic renal neoplasm LMP

Papillary RCC

(NB: papillary adenoma <15mm, pRCC > 15mm)

Oncocytic and chromophobe

Collecting duct carcinoma

Other:

Clear cell papillary renal cell tumour

Mucinous tubular and spindled RCC

Tubulocystic RCC

ACD of kidney- associated RCC

Molecularly Defined Tumours:

SDH deficient RCC

FH deficient RCC

ALK rearranged

SMARCB1 deficient renal medually carcinoma

TFE3-rearranged RCC

TFEB-rearranged RCC

ELOC mutated RCC

17
Q

WHO 2022 Kidney Tumours - Not of renal tubule origin

A

Metanephric Tumours

Metanephric adenoma

Metanephric adenofibroma

Metanephric stromal tumour

Mixed Epithelial and Stromal Tumour

Adult Renal Mesenchymal Tumours

AML and eAML

Renal haemangioblastoma

Juxtaglomerular cell tumour

Renomedullay interstitial cell tumour

18
Q

Reporting Elements for Paediatric Kidney Tumour

A

Procedure and Laterality

Nephrectomy Weight - grams

Tumour Focality (uni or multi)

Histologic Type of Tumour (and Anaplasia in Wilns)

Tumour Size

Integrity of Gerotas Fascia

Renal Sinus Involvement

Renal Vein Involvement

Extension beyond Renal Capsule

Direct Extension into Adjacent Organs

Nephrogenic Rests

Posttherapy Histologic Classification (Int Soc Paed Onc)

(how much tumour is viable, percentage of blastema)

Margins

Lymph Nodes

Metastases

Pathologic Stage : COG Staging System (not for RCC)

19
Q

How to Cut Up Kidney for Wilms Tumour

A

PPE, 3 points of ID, orient specimen.

Check MDM (site, size, pre or post treatment).

Weigh and measure in 3D. Measure ureter and vessels.

Photograph and ink.

Bivalve. Take fresh tissue for tumour banking or rapid H&E if pre treatment. Then fix for 24 - 48 hours.

Shave margins of ureters and vessels. Check renal vein.

Measure kidney and adrenal gland. Slice thinly and photograph for blocking diagram.

Measure tumour in 3D, described cut surface and relationship to structures and margins.

Describe background kidney - look for nephrogenic rests.

Block renal sinus fat and several further blocks of edge of tumour to closest margins / perinephic fat / adjacent structures. Block background kidney / rests. Document on photo blocking diagram.

Lymph nodes.

20
Q

Processing Renal Biopsies

A

Native Kidney

1 core in formalin, 1 core in MIM (Michels Transport Medium)

Core in MTM is examined under dissecting microscope to identify the gloms. This end of core is taken and split for EM (glutaraldehyde) and DIFL (into fridge).

Formalin fixed tissue is processed as per usual then cut

Thin (1-2 micron) slides for:

H&E x 3

PAS x 3

Jones Silver x 3

Masson trichrome x 3

+/- Sirius Red (thick, 6 microns)

DIFL uses antibodies against:

IgG, IgA, IgM, C3, fibrin. Kappa and lamba also available as DIFL.

21
Q

Special Stains in Medical Kidney

A
  1. PAS: BMs, glycogen, mucopolysaccharides, some mucins, sclerosis, amyloid (weakly +)
  2. Jones Silver: BMs, membrane spikes, sclerosis, K-W nodules
  3. Masson Trichrome: nuclei = blue / black, collagen = blue / green, cytoplasm, muscle and RBC’s red. Shows fibrosis and collagen deposition (black), fibrin thrombi (dark red).

Plus Sirius Red or Congo Red for amyloid.

22
Q

Cresenteric GN

A

Severe form of GN in which >50% or more of the glomeruli are affected by epithelial crescents.

Clinical syndrome = RPGN, rapid decline in eGFR with haematuria, red cell casts, variable proteinuria and oliguria.

Causes:

1. Anti GBM Nephritis

  • serum anti-GBM antibodies, linear IgG in GBM on DIFL, no EDD on EM, may have lung involvement (Goodpastures)

2. Pauci-Immune GN

  • ANCA associated, no IF staining or EDD on EM. May have vasculitis. Associated with GPA, EGPA, MPA.

3. Immune Complex Mediated

  • Associated with GN e.g IgA nephropathy, lupus, post-infectious, MPGN, cryoglobulinemic - findings depend on underlying cause
23
Q

Amyloidosis in Kidney

A

Eosinophilic homogenous pink stuff in GBM, TBM, mesangium and capillary walls

Congo Red positive, weakly PAS positive, pale grey / blue on Trichrome

Linear non branching fibrils 6 - 10nM on EM

Need to kappa and lambda ISH or DIFL to exclude AL amyloid

Causes of amyloid:

Neoplasm associated (AL, AH)

Chronic inflammation associated (AA)

Hereditary or Mutation associated (ATTR, AAPO)

Other: sporadic / aging related, dialysis related, alzheimer’s

24
Q

Diabetic Nephropathy

A

Diffuse thickening of GBM and vascular BM

Insudative lesions (fibrin caps, capular drops, arteriolar hyalinosis)

Microaneurysms of capillary loops

Segmental mesangial Kimmelstiel-Wilson nodules

DDx: nodular glomeruolsclerosis i.e. KW nodules = amyloid and light chain deposition disease

25
Q

Minimal Change Disease

A

Most common cause of idiopathic nephrotic syndrome in kids

In adults may be secondary to drug hypersensitivity or lymphoma

Glomeruli appear normal or show minimal abnormality by LM

Complete foot plate effacement on EM with basement membrane covered by cytoplasm only, numerous microvilli also seen

NB: remember sampling error! Level to look for FSGS. Interstitial fibrosis and tubular atrophy not a feature of MCD esp. in kids so if present level to extinction +/- request repeat biopsy

26
Q

Normal thickness of GBM

A

The GBM is one of the thickest basement membranes in the body.

The thickness of the GBM increases from birth to the adult average of 305 nm for women and 330 nm for men.

27
Q

Membranous Nephropathy

(aka membranous glomerulonephritis)

A

Can be primary (idiopathic) or secondary to: drugs, infection (Hep B, syphilis), tumours or autoimmune diseases.

Immune complex mediated: Antibodies react with antigen on underside of podocytes→ activate complement→ effaced podocytes lose slit diaphragm (lose size barrier) and produces more basement membrane between complexes (alters charge barrier) → form spikes

H&E: Diffuse thick membranes

Jones Silver: Spikes

IF: Granular IgG and C3 complexes

Can do specific PLA2R staining for primary MGN

EM: Subepithelial electron dense deposits with spikes of membrane in between

28
Q

FSGS

A

Focal (<50% of glomeruli; vs diffuse)

Segmental (<50% of each glomerulus; vs global)

Adults and children with nephrotic syndrome, microscopic haematuria, reduced eGFR

Steroid resistant, 40 - 60% progress to ESRD, can recur in graft.

Primary (idiopathic) or secondary (drugs, viral infection incl. HIV, healed glomeruolnephritis, mediated by adaptive-functional response)

NOT immune complex mediated!

Several variants: collapsing (poorer prognosis), tip lesion (better prognosis) cellular, perihilar

LM: Focal & segmental sclerosis, uninvolved gloms look ok

IF: Trapped IgM &C3 in sclerotic areas (passive not real complexes)

EM: Widespread effacement of foot processes

29
Q

Post Infectious Glomerulonephritis

A

More common in children, 1-4 wks after infection classically after Group A Strep (S. pyogenes) though Staph infection more common

Present with fever, malaise, smoky urine, oliguria, low serum complement; ASO titers

Immune mediated: Circulating complexes or planted antigen→ bound by antibodies → complement activation → recruit PMNs → break down GBM & podocytes with big holes → leak RBCs with some protein → glomerular cells proliferate and hypertrophy

H&E: Hypercellular gloms, PMNs, occluded lumens, +/- crescents

IF: IgG, C3, “Lumpy bumpy” granular

EM: Subepithelial humps, focal subendothelial and mesangial deposits without GBM reaction to deposits (as seen in membranous)

Good prognosis with usual spontaneous resolution

30
Q

IgA Nephropathy

A

Most common glomerulonephritis worldwide

Often follows a respiratory or GI illness

Recurrent haematuria with mild proteinuria

Genetic or acquired abnormality of immune regulation: elevated serum IgA levels so abnormal IgA immune complexes accumulate in mesangium. IgA-antigen immune complexes in circulation → planted in the mesangium→ mesangial cells proliferate

H&E: Normal or Mesangial widening

IF: Mesangial IgA deposition

EM: Mesangial deposits Can see crescents, sclerosis, or endocapillary proliferation too.

Essentially, Kidney part of HSP.

31
Q

Lupus nephritis

A

Causes diverse renal disease and present in almost any way: Nephrotic, nephritis, asymptomatic, or mixed → major cause of morbidity and mortality in lupus!

Most common in women of child-bearing age. Acute or insidious in onset; chronic remitting and relapsing course

Primary target organs: skin, joints, kidney, serosal membranes

ANA is highly sensitive but not very specific. Anti-dsDNA and anti-Sm antibodies are less sensitive but more specific

H&E: Diverse (5 recognized patterns)

IF: “Full House” all antibodies (IgG, IgM, IgA) and complements (C3, C1q)

EM: Tubuloreticular inclusions (TRI) are commo

32
Q

Alport Syndrome

A

Inherited collagen type IV mutation. Mostly X-linked dominant (males)

Present with asymptomatic hematuria/proteinuria. Progressive loss of renal function. Sensorial deafness. Ocular abnormalities.

H&E: global & segmental sclerosis; interstitial foam cells and FSGS pattern.

IF: Absence of staining with specific collagen type IV subunits

EM: S_plitting and lamellation of GBM_s (basket weave)

33
Q

Synoptic Report for Neuroblastoma

A

Procedure, tumour site, tumour size

Previous neoadjuvant therapy

Histologic subtype, degree of differentiation, MKI, age of patient -> favourable or unfavourable histology

Treatment Effect: % of tumour necrosis and % of therapy induce cytodifferentiation

Lymph nodes

Metastasis

NB: post NAT the diagnosis remains unchanged e.g. “Poorly differentiated NB, status post chemotherapy”

34
Q

Molecular Prognostic Markers in Neuroblastoma

A

Worse prognosis associated with:

MYCN amplificatoin

ALK mutation and amplifcation

1p deletion, 11q deletion, 17q gain

35
Q

Syndromes Associated with Neuroblastoma

A

Germline PHOX2B mutation

Beckwith-Wiedemann syndrome

Hircshsprung disease

Turner syndrome

NF1

36
Q

International Neuroblastoma Classification System

A

Revised Shimada system for classification of NB into favourable and unfavourable histology groups.

Schwanninan stroma poor:

Neuroblastoma, undifferentiated

Neuroblastoma, poorly differentiated

Neuroblastoma, differentiating

Schwannian stroma rich:

Intermixed ganglioneuroblastoma

Gangioneuroma, maturing

Ganglioneuroma, mature

Nodular ganglioneuroblastoma:

Composite stroma rich / stroma poor with grossly visible nodule

Then combine with age & MKI to decide FH / UFH